EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual‐Mechanism Suppression of Posterior Capsule Opacification by an MMP2/9‐Responsive Sulforaphane‐Eluting Intraocular Lens

Ying-Yan Mao, Shi-Chao Zhao, Jin-Fei Wei iD, Jian-Ying Liu, Chun-Bo Dong, Hui-Cong Zheng iD, Jing-Shang Zhang iD, Tao Jiang iD, Meng Li iD, Xiu-Hua Wan iD

Advanced Healthcare Materials · 15.11.2026

DOI: 10.1002/adhm.71900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 15.11.2026. Verfasst von Ying-Yan Mao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Posterior capsule opacification (PCO) is the most frequent complication of cataract surgery and is driven by the epithelial‐mesenchymal transition (EMT) of residual lens epithelial cells (LECs). The current standard of care, Nd:YAG laser capsulotomy, is reactive and carries well‐documented complications, underscoring the need for proactive pharmacological prophylaxis. Drug‐eluting intraocular lenses offer a localized delivery platform. Here, we developed a sulforaphane (SFN)‐eluting intraocular lens (GelMA‐SFN@IOL) by integrating SFN‐loaded gelatin methacryloyl (GelMA) microparticles onto the IOL haptics. The GelMA carrier was designed to respond to MMP‐2/9, which were upregulated in PCO‐associated capsular tissues. In vitro, MMP‐2 enhanced SFN release from GelMA‐SFN microparticles, supporting enzyme‐responsive release behavior. In TNFα‐stimulated HLE‐B3 cells, SFN suppressed LEC migration and EMT marker expression, accompanied by increased autophagic activity and reduced MMP‐2/9 expression. These findings suggest a potential feedback mechanism whereby SFN‐mediated MMP downregulation could reduce enzyme‐promoted carrier degradation and release as the pathological signal subsides. In a rabbit PCO model, GelMA‐SFN@IOL preserved capsular clarity and reduced aberrant LEC proliferation over 28 days, with no obvious histological abnormalities in the examined ocular tissues. Together, these results support a proof‐of‐concept strategy combining an enzyme‐responsive carrier with an MMP‐modulating therapeutic for early post‐surgical PCO prevention, with potential for self‐limiting release.

Schlagwörter

Stichwörter der Autor:innen

epithelial‐mesenchymal transitionintraocular lensmatrix metalloproteinaseposterior capsule opacificationsulforaphane

Autor:innen und Institutionen

  • Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, China.
  • Engineering Research Center of Ophthalmic Equipment and Materials, Ministry of Education, Capital Medical University, Beijing, China.
  • Beijing Key Laboratory of High-Entropy Energy Materials and Devices, Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China.
  • School of Nanoscience and Engineering, University of Chinese Academy of Sciences, Beijing, China.

ORCID-Profile: Jin-Fei Wei, Hui-Cong Zheng, Jing-Shang Zhang, Tao Jiang, Meng Li, Xiu-Hua Wan

Förderung

  • National Natural Science Foundation of China
  • Beijing Nova Program

Zitieren

APA

Mao, Y. Y., Zhao, S. C., Wei, J. F., Liu, J. Y., Dong, C. B., Zheng, H. C., Zhang, J. S., Jiang, T., Li, M., & Wan, X. H. (2026). Dual‐Mechanism Suppression of Posterior Capsule Opacification by an MMP2/9‐Responsive Sulforaphane‐Eluting Intraocular Lens. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71900

Vancouver

Mao YY, Zhao SC, Wei JF, Liu JY, Dong CB, Zheng HC, et al. Dual‐Mechanism Suppression of Posterior Capsule Opacification by an MMP2/9‐Responsive Sulforaphane‐Eluting Intraocular Lens. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71900

BibTeX
@article{Mao2026,
  author = {Mao, Ying-Yan and Zhao, Shi-Chao and Wei, Jin-Fei and Liu, Jian-Ying and Dong, Chun-Bo and Zheng, Hui-Cong and Zhang, Jing-Shang and Jiang, Tao and Li, Meng and Wan, Xiu-Hua},
  title = {Dual‐Mechanism Suppression of Posterior Capsule Opacification by an MMP2/9‐Responsive Sulforaphane‐Eluting Intraocular Lens},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71900}
}
Kostenlos starten →